Clinical Trials Browser

DNA Repair-Deficiency Disorders × pembrolizumab × 90 days × Clear all

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, DNA Repair-Deficiency Disorders